Moneycontrol PRO
HomeNewsOpinionAs investments rise at Sun Pharma, watch out for impact on profit margins

As investments rise at Sun Pharma, watch out for impact on profit margins

The company has extended its agreement with Philogen to commercialise an immunotherapy drug globally

October 07, 2024 / 09:38 IST
File picture
Unlock This Article

Are you a PRO subscriber? Sign In

What Do You Get

  • Ad free Experience

    Seamless navigation, faster responses.

  • Expert Perspective

    Explore 230+ exclusive editorials every month

  • +

    Uncover Insights from World-Renowned Experts and Journalists

  • Actionable Insights

    40+ weekly investment ideas + 3 to 4 daily technical calls

  • Virtual Events

    Exclusive Live Webinars for Expert Trading & Investment Strategies!

  • Newsletters

    Stay ahead with daily and weekly insights

Unlock exclusive discounts